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ABSTRACT 
The role ofmalnutrition and diet in general on bioprocess, which 
govern the fate of drug/xenobiotic in the body only just beginning to 
be understood. Absorption, protein binding distribution, 
bio-transformation and renal elimination of xenobiotics/drugs are all 
affected by altered states of nutrition. As such, evaluation of nutritional 
status is highly relevant prior to prolonged drug thereby especially with 
drugs having narrow safety margin. 
1. INTRODUCTION 
In recent years, the impact of environment on man is gaining a wide recognition 
as we are exposed to a wide variety of chemicals foreign to the body. Toxicology is 
a science which deals with qualitative and quantitative aspects of environmental effects 
on biological tissues and their mechanisms. The implications of toxicity or influence 
of xenobiotics in terms of dose and duration of exposure are explored with regard to 
absorption, distribution, elimination and action of toxicants in human body. Thus the 
interaction of chemicals with the biological system is a ,complex phenomenon and is 
ultimately an expression of the interplay between the environment, the host and 
chemical substance. The three important phases namely the exposure phase 
(Pharmaceutical), the toxicokinetic phase (Pharmacokinetic) and the toxicodynamic 
phase (Pharmacodynamic) will directly determine the outcome of drug response or 
toxicity manifestations (Fig. 1). 
A number of internal and external factors can modify these phases. '.* The physico- 
chemical prospective of xenobiotics/drugs and the physiological and pathological 
variables of the host will determine the entrance and the exit of xenobiotic drug from 
the body. The ultimate outcome of the drugltoxicant is therefore a summation of 
Received 29 September 1986 
133 
Kamala Krishnaswamy 
TOXlCOLOGY PHARMACOLOGY 
DOSE, DURATION FORM PHARMACEUTICAL 
PHASE AND ROUTE OF EXPOSURE PHASE 
TOXlCOKlNETlC 
PHASE ORGAN SPECIFICITY 
PHARMACOKINETIC 
PHASE 
TOXICODYNAMIC RE CTPr OR$-H T E RAC PION I - PHARMACODYNAMJC 
PHASE IMOLECULM EVENT)  PHASE 
"
EXPRESSION -1 DRUG RESPONSE OR 
) TOXICITY OBSERVATION 
Figure 1. Interaction between chemicals and human body. 
effects observed as a therapeuticltoxic processldiseases: A number of factors as shown 
in Table 1 are known to be involved in this p r o ~ e s s . ~  
Table 1. Toxicity determinants 
1 Site of entry 6 Elimination profile 
2 Membrane bamers 
3 Distribution and tissue specificity 
4 Binding characters 
7 Dose related effects 
8 Combination factors 
9 Inducingtinhibiting potency 
5 Metabolic profile 10 Pool location, size, reaction intermediates 
Food is a prerequisite for existence and good health of man, and is an important 
link between man and his environment. Nutrition associated toxicity problems are 
both of basic and applied interest and a topic of current ~ o n c e r n . ~  The physical, 
physiological and pathological interactions between diet and xenobiotics influence 
nutritional processes and alter drug/xenobiotic metabolism, disposition, potency and 
toxicity. However, food in addition to supplying nutrients, may also serve as vehicle 
for toxins. The toxicants may be naturally occurrink toxin (inorganic substances, toxins 
of microbial origin, plant products or organic compounds) or food additives such as 
preservatives, colours, sweeteners, flavouring agents etc. In addition, food 
contaminants such as pesticide and herbicide residues, water and other pollutants are 
further sources of toxicants. Drugs or pharmaceutical products, which are used to 
cure diseases are also xenobiotics with both therapeuticltoxic potentials. 
Hence it is necessary to consider the role of nutrients in xenobioticldrug 
metabolism and disposition and the effect of xenobiotics on niltrient absorption, 
metabolism and excretion. 
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2. MALNUTRITION 
For nutritionists and other professionals in health, drug disposition, 
nutrition-drug/xenobiotic interaction has become a challenge and a responsibility. The 
role of malnutrition and diet in general on bioprocesses which govern the fate of 
drug/xenobiotic in the body are only just beginning to be under~tood.~ The nutrients 
in the diet and the nutritional status can considerably alter these processes and 
modifying amount of drug/toxicant available. for action. 
The major nutritional disorders which are widely prevalent in all developing 
countries are protein energy malnutrition (PEM), vitamin A deficiency, iron deficiency 
anaemia, vitamin B complex deficiency and iodine deficiency. They affect all age 
groups and more so of poorer segments of the population. However, the repercussions 
are strongest in children and pregnant or lactating women.6 
A number of pathophysiological charrges are encountered in nutrient deficient 
states. They affect gastrointestinal tracts, body composition and fluids, plasma/tissue 
proteins, organ functions such as liver and kidney and heart. In addition a host of 
endocrinal and metabolic changes occur,' which have a great potential to alter 
xenobiotic absorption, distribution, binding, metabolism and excretion. The 
alterations and the clinical significance are briefly considered here. 
2.1 Absorption of Toxicants/Drugs 
Most xenobiotics including drugs are lipophilic substances. They are either 
absorbed passively or actively along the mucous membrane. Along the food chain, 
the load of pollutants invariably increases. The uptake of xenobiotics is invariably 
higher from the gastrointestinal tract, in which the concentration is high than from 
the environment. However, it is possible that due to alterations in the mucous 
membrane and gastrointestinal functions, absorption of xenobiotics may decrease. 
Drugs such as antibiotics and nutrients absorption such as iron, vitamin BIZ are known 
to go down in malnutrition.' Very little is known about xenobiotic absorption in 
malnourished human host. However, several studies indicate that food per se can 
either increase or decrease absorption of drugs9 
2.2 Binding and Distribution 
Most xenobiotics are transported in blood bound to proteins, albumin and 
globulin.10 The extent of binding varies according to the chemical nature of 
drugs/xenobiotics and its affinity for the protein. Since protein-drug complexes cannot 
cross tissue barrier, the free druglxenobiotics is an important determinant of both 
toxicokinetic (Pharrnacokinetic) or toxicodynamic (Pharmacodynamic) effect of 
xenobiotics. 
The qualitative and quantitative changes in food can directly influence the plasma 
protein profile and the binding of xenobiotics. Many endogenous substrates such as 
free fatty acids, bilirubin, steroids, thyroid hormones, tryptophan, histamines and uric 
acid bind to albumin. A significant reduction in binding of several drugs has been 
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observed in malnutrition both in adults and children." Free cortisol levels are known 
to be elevated in ma~nutrition.'~ 
The significance of drug protein binding is often debated. The alterations in 
binding can however lead to variabilities in other pharmacokinetic parameters. The 
organ clearances of drugs and xenobiotics will be ultimately determined by unbound 
free fraction. If the free drug clearance is low, relative to the organ blood flow the 
clearance is always depepdent on the binding properties. Therefore the xenobiotic 
and drug clearances will be altered depending upon the protein-drudtoxicant 
interaction. If free drug concentration are higher, elevation in drudtoxicant responses 
for non restrictive clearance of drugs have been demonstrated.13 
The uptake of the xenobiotics and drugs by various organs and tissues will depend 
upon the organs or tissues specificitylaffinity as well as receptor drug interactions. 
Both proteins and fats in the body are directly determined by nutrients and food 
components. The drug distribution is significantly altered in obesity. In the 
malnourished human host there is a significant reduction in adipose mass as well as 
lean body mass which therefore would alter the distribution characters. The distribution 
into adipose tissue of lipid soluble substances such as pesticide residues and drugs 
like tetracycline will automatically be reduced.I4 The clinical implications for such 
reductions would therefore be of significance and the responses would vary depending 
upon the extent of reduction as well as the clearance characters of the drug. 
Concentration of lipid soluble substances will increase at target tissues. 
2.3 Biotransformations 
Diet and nutrition have been identified as major factors which influence the 
chemical transformations of drugs and other xenobiotics in experimental situations."-'* 
The effects of foreign compounds in general are regulated by their. metabolism by 
enzymes located in the endoplasmic reticulum in liver and other tissues such as lungs, 
kidneys, intestine, skin, brain, adrenals, blood cells and placenta. The liver, however, 
is by far the most important organ for the metabolism of foreign compounds. The 
biotransformation of environmental chemicals involves Phase I (oxidation, reduction, 
hydrolysis) and Phase I1 (conjugation) processes mediated by mixed function oxidase 
and conjugation enzymes. The components of the multienzyme system are 
haemoprotein cytochrome P450, a flavoprotein-NADPH cytochrome P450 reductase 
and lipid phosphatidyl choline. 
The enzyme system has a wide substrate specificity. The balance between 
intracellular reactions that result in activation of a specific compound to a more 
reactive form and those detoxification reactions that make the compound less reactive 
determines the extent of cellular d~mage  and toxicity expression. The enzyme activity 
per se is an expression of interplay of genetic, environmental, physiological and 
pathological factors which directly determine drug or xenobiotic activity and toxicity. 
A number of nutrients are known to be involved in the functioning of these 
enzymes (Fig. 2), either participate in the overall functioning or act as cofactors or 
as substrates in the enzyme activity or are involved in membrane stability. In 
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Figure 2. Nutrients and biotransformations. 
experimental situation, nutritional stress has often been shown to alter the activity of 
these enzymes. These alterations have been shown to be dependent on species, stress. 
age, sex, type and degree and duration of nutritional deprivation and also On the type 
of substrates being In general, all specific deficiencies except those 
of thiamine and iron, decrease metabolism of d r ~ g s . ' ~ ? ~ ~  Oxidative metabolism is often 
diminished and also the conjugations are decreased in starvation. In chronic 
semi-starvation, mixed function oxidase activity is higher with no change or decrease 
in conjugations (Table 2). Protein deficiency is known to decrease the mixed function 
Table 2. Nutritional status and enzyme function 
Condition Mixedfunction Glucuronyl Glucuronyl Glutathione-S- 
oxidase transferase transferase 
Acute 
Chronic (semi) 
Protein deficiency 
( 5%)  
Carbohydrates 
(glucose. sucrose, 
fructose) 
LipiddLipotropes 
1 No change No change 
No change 
138 Kamala Krishnaswarny 
oxidase activity with variable effect on conjugations. Lipid deficiency in general 
decreases the enzyme levels. The ability of animal studies of nutritional adequacy or 
inadequacy to predict pharmacological effects in man is ambiguous. Animal studies 
cannot always be extrapolated to humans and have to be viewed with a great caution.'l 
Single nutrient deficiency and excess do not exist in the population. The nature of 
the nutritional deprivation both in terms of duration and degree are not comparable 
to human situations. 
Therefore, attempts have been made to obtain information in human subjects in 
the naturally existing situations in and in ~h i ld ren~ '*~~r  as well as in 
experimental situations where dietary modifications have been attempted.".25 The 
clearance of drugs are decreased in severe cases of malnutrition such as kwashiorkor, 
marasmus and nutritional oedema. Xenobiotics have a tendency to accumulate due 
to decreased clearance of drugs such as phenazone, chloramphenicol, chloroquine, 
paracetamol, phenylbutazone, isoniazid and sulphadiazine in ~ h i l d r e n . ~ ~ . ~ ~  In adults, 
however, clearance of drugs depends upon the severity of the nutritional status. The 
oxidative metabolism of drugs is enhanced either due to nutritional/e~~vironmental 
stress in cases of mild and moderate malnourished subjects." It has also been observed 
that in children with malnutrition, vitamin D hydroxylations are comparable to that 
of normal subjects." On the other hand, nutrition effects on conjugations are variable. 
Metabolism of contraceptive steroids are found to be faster in undernourished 
~ o m e n . ~ ~ . ~ '  The diminution and endogenous estradiol activity due to faster conversion 
of steroids is also do~umented.~' On the other hand, paranitrophenol conjugation is 
lowerein undernourished subjects." 
Metabolic experiments in adults on varying energy and protein intake indicate 
that very low protein intake resulting in negative nitrogen balance decreases drug 
metabolism whereas on adequate calories minor differences in protein intake of the 
order of 5-10 per cent do not have any significant impact3'. Protein in the diet 
contributes to 20-40 per cent of energy results in stimulation of enzymes leading to 
faster clearance of drugs and xenobiotirs." In energy deficiency recenr observation 
indicate no change in drug clearance whereas in severe protein deficiency clearances 
decreased .33 
In addition to the nutrients, non-nutrient components in the diet are also known 
to significantly enhance or reduce drug metabolism and clearance.= Several studies 
indicate that plant chemicals such as indoles, flavones, phenols and isothiocyanates 
can stimulate drug metabolism in man. Cruciferous vegetables such as cabbage and 
brussel sprouts increase clearance of antipyrine and theophylline." Though 
experimental evidences are available on either induction or inhibition, no data is 
available to indicate that the dietary inducers and inhibitors significantly alter the 
therapeutic and toxic effects of drugs and xenobiotic~.~~ However, strong inducers 
such as drugs per se are known to result in important drug-drug interactions which 
are of therapeutic significance. 
In addition to macro nutrients, micro nutrients deficiency needs to be considered 
in human population. Very little information is available in humans. Iron deficiency 
in humans have been shown to increase drug clearance. Zinc deficiency, on the other 
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hand is associated with decrease enzyme activity and clearance of drugs. Drug 
metabolism in general has not been explored in depth in micro nutrient deficiency. 
2.4 Renal Elimination of Drugs 
Urinary excretion is the primary route of elimination for water soluble drugs and 
their metabolism. Controversial reports exist on kidney function in malnutrition. The 
recent data on renal function reserve indicate that kidney function can be related to 
protein intake.36 Diet induced changes in pH and ionisation of drugs will also alter 
renal elimination of drugs. Studies conducted on drugs which are excreted by kidney 
in severe malnutrition indicate that the clearance is decreased by renal route. On the 
other hand in mild and moderate forms, kidney function is in tact and drug clearances 
are enhanced due to alterations in binding and availability of free drugs. 
3. PHARMACODYNAMICS : RECEPTORS, DRUG RESPONSE AND TOXICITY 
Drug receptor interactions are difficult to evaluate and information on magnitude 
of response is limited. Studies on hormonal receptors indicate that nutritional status 
alters receptor ~ensit ivity.~~ Such alterations may have repercussions not only on 
clinical response but also determine susceptibility to organ damage. Higher 
requirements for propranolol and prazosine has been demonstrated in African Negro 
patients probably indicating altered Theophylline responses have been 
noted to be better in children who are on very low protein intake.40 
Studies in animals indicate that nutritional status is an important determinant of 
drug toxicitie~.~' The various permutations are shown in Table 3. Anthracycline has 
been associated with cardiomyopathy more in malnourished children. Acetaminophen 
toxicity is also documented to be higher in malnutrition. Hypoalbuminaemia is often 
associated with more toxic reactions." Recently the subject of toxicity through 
metabolic activation is widely studied. Our results in mild and moderate 
undernaurished adults indicate that the mixed function oxidase activity is in an induced 
state and therefore the undernourished are more at risk of developing toxic 
metabolites." It is also interesting to observe that aflatoxin metabolites are higher in 
children with kwash i~rkor .~~  The deleterious effects of exposure to high levels of such 
toxic compounds in the presence of undernutrition may precipitate toxicity at early 
stages and result in higher incidence of diseases associated with such toxicity. However, 
it is important to remember that the toxicological significance of induction differs 
from substrate to substrate, the quantum of induction and tissues in which the enzymes 
are induced. Inducers and inhibitors can have significant effect on the toxic and 
carcinogenic effect of chemicals.44 Nutritional modulations of the inducing and 
inhibiting effect of chemical may also make it either more or less susceptible for 
tumour production. It is possible that the cycle of altering food shortage and food 
sufficiency which are encountered in poor communities may have consequences beyond 
the obvious ways of hunger and brief nutritional deficit.45 However based on the 
incidence of human cancers in relation to diet46 and experimental studies in animals47 
and the effect of nutrients on carcinogen metabolism, it may be surmised that certain 
diseases such as cancer can be related to the effect of nutrients on drug metabolising 
enzymes.48 
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4. CONCLUSION 
It is evident from available literature that a number of druglxenobiotic nutrient 
interactions can result in altered response/toxicity which are of clinical relevance. 
Hence, it is necessary to evaluate the nutritional status before instituting drug therapy 
particularly for prolonged periods of time. Dietary modifications may be called for 
adequate therapeutic response. Clinical and epidemiological data have yet to be 
explored in depth in malnourished subjects particularly on efficacy, and acute and 
chronic toxicity of drugs. Drugs with narrow margin of safety with dose dependent 
kinetics and with severe toxic reactions need to be evaluated in malnutrition. 
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